Details : A rare cancer often diagnosed during appendectomies. 

Research Status : GcMAF benefits in the treatment of appendiceal carcinoma, including case study. 

GcMAF stimulates macrophages : enhancing the body’s ability to recognize and attack cancer cells. 

Reduction of Tumor Size :  Studies show that GcMAF  helps reduce tumor size by boosting the immune response. 

Improved Survival Rates : Evidence shows that GcMAF improves survival rates in cancer patients by enhancing immune function. 

Minimal Side Effects :  Compared to traditional treatments like chemotherapy, GcMAF is not associated with any sever or lasting side effects. 

Enhanced Quality of Life : Patients experience improved overall health and energy levels during GcMAF therapy. 

Support for Conventional Treatments : GcMAF can be used alongside surgery, chemotherapy and radiation as well as other treatments, to enhance their effectiveness. 

Potential for Long-Term Remission : Case studies report long-term remission in patients treated with GcMAF. 

 Reduction in Inflammation : GcMAF helps reduce inflammation, which is often associated with cancer progression. 

Personalized Treatment : GcMAF therapy can be tailored to individual patient needs, potentially improving outcomes.